Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Gerstein

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trialA M Sawka, H C Gerstein, M J Marriott, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 18, 2006
A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) StudyH C Gerstein, J-F Yale, S B Harris, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 10, 1999
A controlled evaluation of a national continuing medical education programme designed to improve family physicians' implementation of diabetes-specific clinical practice guidelinesH C Gerstein, S S Reddy, K G Dawson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 19, 2010
Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trialE J Boyko, H C Gerstein, V Mohan, et al.
Endocrine|August 21, 2009
Effects of rosiglitazone on ovarian function and fertility in animals with reduced fertility following fetal and neonatal exposure to nicotineJ J Petrik, H C Gerstein, C E Cesta, et al.
Circulation|March 7, 2007
Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular riskC Held, H C Gerstein, S Yusuf, et al.
Journal of Diabetes and Its Complications|April 2, 2014
Cost implications of the use of basal insulin glargine in people with early dysglycemia: the ORIGIN trialA Lamy, W Tong, H Jung, et al.
Atherosclerosis|February 16, 2013
Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient miceK J Veerman, D E Venegas-Pino, Y Shi, et al.
Diabetologia|November 5, 2005
Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetesA C Holloway, G E Lim, J J Petrik, et al.
Diabetologia|August 2, 2005
The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysisH C Gerstein, J Pogue, J F E Mann, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trialA M Sawka, H C Gerstein, M J Marriott, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 18, 2006
A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) StudyH C Gerstein, J-F Yale, S B Harris, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 10, 1999
A controlled evaluation of a national continuing medical education programme designed to improve family physicians' implementation of diabetes-specific clinical practice guidelinesH C Gerstein, S S Reddy, K G Dawson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 19, 2010
Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trialE J Boyko, H C Gerstein, V Mohan, et al.
Endocrine|August 21, 2009
Effects of rosiglitazone on ovarian function and fertility in animals with reduced fertility following fetal and neonatal exposure to nicotineJ J Petrik, H C Gerstein, C E Cesta, et al.
Circulation|March 7, 2007
Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular riskC Held, H C Gerstein, S Yusuf, et al.
Journal of Diabetes and Its Complications|April 2, 2014
Cost implications of the use of basal insulin glargine in people with early dysglycemia: the ORIGIN trialA Lamy, W Tong, H Jung, et al.
Atherosclerosis|February 16, 2013
Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient miceK J Veerman, D E Venegas-Pino, Y Shi, et al.
Diabetologia|November 5, 2005
Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetesA C Holloway, G E Lim, J J Petrik, et al.
Diabetologia|August 2, 2005
The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysisH C Gerstein, J Pogue, J F E Mann, et al.
Pageof 9